These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33102585)

  • 41. Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2.
    Mohammad A; Alshawaf E; Marafie SK; Abu-Farha M; Al-Mulla F; Abubaker J
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33919870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SARS-Coronavirus-2 Nsp13 Possesses NTPase and RNA Helicase Activities That Can Be Inhibited by Bismuth Salts.
    Shu T; Huang M; Wu D; Ren Y; Zhang X; Han Y; Mu J; Wang R; Qiu Y; Zhang DY; Zhou X
    Virol Sin; 2020 Jun; 35(3):321-329. PubMed ID: 32500504
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Mateev E; Georgieva M; Zlatkov A
    Comb Chem High Throughput Screen; 2023; 26(6):1242-1250. PubMed ID: 35984023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structure-based virtual screening methods for the identification of novel phytochemical inhibitors targeting furin protease for the management of COVID-19.
    Kumar Tiwari P; Chouhan M; Mishra R; Gupta S; Chaudhary AA; Al-Zharani M; Ahmed Qurtam A; Nasr FA; Jha NK; Pant K; Kumar M; Kumar S
    Front Cell Infect Microbiol; 2024; 14():1391288. PubMed ID: 38919703
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plant-derived chemicals as potential inhibitors of SARS-CoV-2 main protease (6LU7), a virtual screening study.
    Sisakht M; Mahmoodzadeh A; Darabian M
    Phytother Res; 2021 Jun; 35(6):3262-3274. PubMed ID: 33759279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. High throughput screening for SARS-CoV-2 helicase inhibitors.
    Otsuka Y; Kim E; Krueger A; Shumate J; Wang C; Bdiri B; Ullah S; Park H; Scampavia L; Bannister TD; Chung D; Spicer TP
    SLAS Discov; 2024 Sep; 29(6):100180. PubMed ID: 39173831
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piece of the puzzle: Remdesivir disassembles the multimeric SARS-CoV-2 RNA-dependent RNA polymerase complex.
    Olotu FA; Omolabi KF; Soliman MES
    Cell Biochem Biophys; 2021 Jun; 79(2):175-187. PubMed ID: 33792836
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses.
    Hu Y; Ma C; Szeto T; Hurst B; Tarbet B; Wang J
    ACS Infect Dis; 2021 Mar; 7(3):586-597. PubMed ID: 33645977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of potent remdesivir derivative against SARS-CoV-2 protease inhibitors: Design, modification, molecular modeling and MD simulations.
    Akhtar M; Shamim S
    Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1119-1126. PubMed ID: 34602441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19.
    Vardhan S; Sahoo SK
    Comput Biol Med; 2020 Sep; 124():103936. PubMed ID: 32738628
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Review on Remdesivir: A Broad-spectrum Antiviral Molecule for Possible COVID-19 Treatment.
    Khazir J; Maqbool T; Mir BA
    Mini Rev Med Chem; 2021; 21(17):2530-2543. PubMed ID: 33596800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design of novel and highly selective SARS-CoV-2 main protease inhibitors.
    Poli ANR; Tietjen I; Nandwana NK; Cassel J; Messick TE; Register ET; Keeney F; Rajaiah R; Verma AK; Pandey K; Acharya A; Byrareddy SN; Montaner LJ; Salvino JM
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0056224. PubMed ID: 39225484
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of the potency of FDA-approved drugs on wild type and mutant SARS-CoV-2 helicase (Nsp13).
    Ugurel OM; Mutlu O; Sariyer E; Kocer S; Ugurel E; Inci TG; Ata O; Turgut-Balik D
    Int J Biol Macromol; 2020 Nov; 163():1687-1696. PubMed ID: 32980406
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploring the therapeutic potential of Thai medicinal plants: in vitro screening and in silico docking of phytoconstituents for novel anti-SARS-CoV-2 agents.
    Maikhunthod B; Chaipayang S; Jittmittraphap A; Thippornchai N; Boonchuen P; Tittabutr P; Eumkeb G; Sabuakham S; Rungrotmongkol T; Mahalapbutr P; Leaungwutiwong P; Teaumroong N; Tanthanuch W
    BMC Complement Med Ther; 2024 Jul; 24(1):274. PubMed ID: 39030504
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimization Rules for SARS-CoV-2 M
    Stoddard SV; Stoddard SD; Oelkers BK; Fitts K; Whalum K; Whalum K; Hemphill AD; Manikonda J; Martinez LM; Riley EG; Roof CM; Sarwar N; Thomas DM; Ulmer E; Wallace FE; Pandey P; Roy S
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32859008
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of the Phytochemical Agents against the SARS-CoV and Some of them Selected for Application to COVID-19: A Mini-Review.
    Idrees M; Khan S; Memon NH; Zhang Z
    Curr Pharm Biotechnol; 2021; 22(4):444-450. PubMed ID: 32619167
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
    Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
    J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of phytochemicals as potential therapeutic agents that binds to Nsp15 protein target of coronavirus (SARS-CoV-2) that are capable of inhibiting virus replication.
    Kumar S; Kashyap P; Chowdhury S; Kumar S; Panwar A; Kumar A
    Phytomedicine; 2021 May; 85():153317. PubMed ID: 32943302
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Alagarsamy V; Solomon VR; Murugesan S; Sundar PS; Muzaffar-Ur-Rehman MD; Chandu A; Aishwarya AD; Narendhar B; Sulthana MT; Ravikumar V
    Curr Drug Discov Technol; 2024; 21(3):73-89. PubMed ID: 37861016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions Between Remdesivir, Ribavirin, Favipiravir, Galidesivir, Hydroxychloroquine and Chloroquine with Fragment Molecular of the COVID-19 Main Protease with Inhibitor N3 Complex (PDB ID:6LU7) Using Molecular Docking.
    Silva Arouche TD; Reis AF; Martins AY; S Costa JF; Carvalho Junior RN; J C Neto AM
    J Nanosci Nanotechnol; 2020 Dec; 20(12):7311-7323. PubMed ID: 32711596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.